R3A-24048-02753
3 vaccinations
4 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 214 / MD
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- G6Z-30625-72742
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-06-22
Dose 1 — Moderna
- 2022-06-22
- 2022-06-23
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-07-06
- 2022-07-13
- 2022-07-20
-
2022-07-25
Dose 2 — Moderna
-
2022-07-26
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-07-31
- 2022-08-01
-
2022-08-08
Survey response — day 14, dose 2, under 3MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever up to 102 degreesMedDRA releases: 2024-11 · check-in free text available
- 2022-08-21
- 2022-08-22
- 2022-08-29
-
2022-09-05
Survey response — day 42, dose 2, under 3MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Fever, cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — 3 months, dose 2, under 3MedDRA: Croup infectious, Hand-foot-and-mouth disease, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Croup, hand foot mouth, a million toddler coldsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-10-25
-
2022-12-22
Dose 3 — Moderna
-
2023-01-23
Survey response — 6 months, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-03-23
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-25 | Moderna | No |
| 3 | 2022-12-22 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Fever up to 102 degrees
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Fever, cough, congestion
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Croup, hand foot mouth, a million toddler colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Croup infectious | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release